ULK1 (UNC-51 Like Kinase 1) is a serine/threonine-protein kinase that plays a central role in initiating autophagy, the cellular process for degrading and recycling damaged organelles, protein aggregates, and intracellular pathogens. Located on chromosome 2q24, ULK1 encodes a 1050-amino acid protein with an N-terminal kinase domain and C-terminal regulatory regions that interact with multiple autophagy-related proteins [1]. The kinase serves as a critical sensor of cellular energy status and nutrient availability, integrating signals from AMPK and mTORC1 to coordinate the autophagic response [2].
The ULK1 complex—comprising ULK1, ATG13, FIP200 (also known as RB1CC1), and ATG101—forms the core initiating machinery for autophagosome formation in mammalian cells. This complex is activated by AMPK-mediated phosphorylation under energy stress conditions and inhibited by mTORC1 during nutrient-rich states [3]. The proper function of ULK1-mediated autophagy is essential for neuronal survival, as neurons rely heavily on autophagy to clear misfolded proteins and maintain mitochondrial health [4].
The ULK1 gene spans approximately 50 kb on chromosome 2q24.3 and consists of 47 exons encoding the 1050-amino acid ULK1 protein (UniProt: Q9P2R7). The protein contains several functional domains:
The related kinase ULK2 (approximately 60% identical) shares functional redundancy with ULK1, though ULK1 appears to play a dominant role in neuronal autophagy [5].
The ULK1 complex consists of four core components:
This tetrameric complex is evolutionarily conserved from yeast Atg1 to mammalian ULK1/2 [6].
ULK1 activation is tightly regulated by cellular energy status:
AMPK-mediated activation: When cellular energy is low, AMPK phosphorylates ULK1 at multiple sites:
These phosphorylations trigger ULK1 kinase activity toward downstream substrates [7].
mTORC1-mediated inhibition: Under nutrient-rich conditions, mTORC1 phosphorylates ATG13 and ULK1, maintaining the complex in an inactive state. Nutrient withdrawal leads to mTORC1 inhibition and ULK1 complex activation [8].
Once activated, ULK1 phosphorylates multiple downstream targets:
In Alzheimer's disease (AD), ULK1-mediated autophagy is impaired at multiple levels:
Amyloid-β clearance: Autophagy normally degrades amyloid-β (Aβ) peptides generated in neurons. ULK1 dysfunction leads to impaired autophagic clearance of Aβ, contributing to extracellular plaque accumulation. Studies show reduced ULK1 activity in AD brain tissue, correlating with decreased autophagic flux [5:1].
Tau pathology: Autophagy also participates in tau protein clearance. ULK1 deficiency leads to accumulation of hyperphosphorylated tau and formation of neurofibrillary tangles. The ULK1-mediated pathway may be particularly important for clearing tau aggregates that resist proteasomal degradation.
Neuronal energy failure: AD brain exhibits significant energy impairment, which should theoretically activate AMPK-ULK1 signaling. However, paradoxically, ULK1 function appears compromised in AD, possibly due to post-translational modifications or oxidative damage to the complex.
ULK1 plays a critical role in mitophagy—the selective autophagy of damaged mitochondria—in dopaminergic neurons:
PINK1/Parkin pathway: ULK1 is recruited to damaged mitochondria in a PINK1-Parkin-dependent manner. ULK1 phosphorylates Parkin and mitophagy receptors, amplifying the mitophagy response. ULK1 deficiency leads to accumulation of dysfunctional mitochondria in dopaminergic neurons [3:1].
LRRK2 interaction: Mutations in LRRK2 (a common genetic cause of familial PD) impair mitophagy. LRRK2 phosphorylates ULK1, and pathogenic LRRK2 mutations dysregulate this phosphorylation, contributing to mitochondrial dysfunction in PD.
Alpha-synuclein autophagy: ULK1-mediated autophagy contributes to clearance of alpha-synuclein aggregates. Impairment of this pathway leads to accumulation of toxic oligomers and Lewy bodies.
In ALS, ULK1 dysfunction contributes to disease pathogenesis through multiple mechanisms:
Stress granules: ULK1 regulates the clearance of stress granules containing aggregated RNA-binding proteins. Impaired ULK1 function leads to accumulation of stress granules, which are a pathological hallmark of ALS.
Mitochondrial quality control: Motor neurons are highly dependent on mitochondrial function. ULK1-mediated mitophagy is essential for maintaining mitochondrial health, and its impairment contributes to motor neuron degeneration.
Protein aggregate clearance: Like other neurodegenerative diseases, ALS involves accumulation of misfolded proteins including SOD1, TDP-43, and FUS. ULK1-mediated autophagy is critical for clearing these aggregates.
ULK1 function is altered in Huntington's disease (HD):
mHTT interference: Mutant huntingtin protein (mHTT) interacts with ULK1 and impairs its function. This contributes to the characteristic accumulation of protein aggregates in HD.
Autophagy inhibition: mHTT also disrupts the recruitment of autophagy machinery to cargo, reducing the efficiency of selective autophagy.
ULK1 is widely expressed throughout the central nervous system with particularly high levels in:
Neuronal ULK1 expression is dynamically regulated:
Targeting ULK1 offers therapeutic potential for neurodegenerative diseases:
Several compounds that enhance ULK1 activity are under investigation:
Viral vector delivery of functional ULK1 to neurons:
ULK1 interacts with numerous proteins in the autophagy network:
| Partner | Interaction Type | Functional Consequence |
|---|---|---|
| AMPK | Phosphorylation | ULK1 activation under energy stress |
| mTORC1 | Phosphorylation | ULK1 inhibition under nutrient abundance |
| ATG13 | Direct binding | Complex scaffold |
| FIP200 | Direct binding | Complex scaffold |
| Beclin 1 | Phosphorylation | Promotes VPS34 activation |
| ATG14 | Phosphorylation | PI3K complex recruitment |
| LC3 | LIR-mediated binding | Autophagosome association |
| PINK1 | Phosphorylation | Mitophagy initiation |
| Parkin | Phosphorylation | Mitophagy amplification |
Egan DF, et al. Phosphorylation of ULK1 by AMPK initiates autophagy. 2011. ↩︎
Mizushima N. The role of the Atg1/ULK1 complex in autophagy regulation. 2010. ↩︎
Lee SB, et al. ULK1-mediated mitophagy in neurodegenerative diseases. 2021. ↩︎ ↩︎
Wu W, et al. ULK1 deficiency contributes to neurodegeneration. 2023. ↩︎
Jove M, et al. ULK1/2 in Alzheimer's disease. 2019. ↩︎ ↩︎
Itakura E, et al. The Atg14 and Bcl-2 homology domain. 2012. ↩︎
Zurita E, et al. The interaction between ULK1 and Beclin 1. 2019. ↩︎
Nazio F, et al. ULK1 complex and mTORC1 inhibition. 2013. ↩︎